Literature DB >> 28438572

Co-administration of tenofovir plus protease inhibitor based antiretroviral therapy during sofosbuvir/ledipasvir treatment for HCV infection: Much Ado About Nothing?

Lucia Taramasso1, Elena Ricci2, Benedetto Maurizio Celesia3, Paolo Bonfanti4, Tiziana Quirino5, Nicola Squillace6, Laura Ambra Nicolini7, Paolo Maggi8, Canio Martinelli9, Giuseppe Vittorio De Socio10, Antonio Di Biagio7.   

Abstract

Entities:  

Keywords:  Hepatitis C virus; Sofosbuvir/ledipasvir; Tenofovir

Mesh：

Substances：

Year:  2017        PMID： 28438572     DOI： 10.1016/j.clinre.2017.03.006

Source DB:  PubMed          Journal:  Clin Res Hepatol Gastroenterol        ISSN： 2210-7401            Impact factor:   2.947


× No keyword cloud information.
  3 in total

1.  Trend of estimated glomerular filtration rate during ombistasvir/paritaprevir/ritonavir plus dasabuvir ± ribavirin in HIV/HCV co-infected patients.

Authors:  Lucia Taramasso; Antonio Di Biagio; Francesca Bovis; Laura Ambra Nicolini; Andrea Antinori; Laura Milazzo; Salvatore Sollima; Guido Gubertini; Fosca Niero; Annalisa Saracino; Raffaele Bruno; Vanni Borghi; Francesca Montagnani; Annamaria Cattelan; Hamid Hasson; Gloria Taliani; Antonella D'Arminio Monforte; Claudio Mastroianni; Giovanni Di Perri; Sara Bigoni; Massimo Puoti; Angiola Spinetti; Andrea Gori; Nicola Boffa; Bruno Cacopardo; Andrea Giacometti; Giustino Parruti; Vincenzo Vullo; Antonio Chirianni; Elisabetta Teti; Caterina Pasquazzi; Daniela Segala; Massimo Andreoni
Journal:  PLoS One       Date:  2018-02-20       Impact factor: 3.240

2.  Real-world effectiveness of direct-acting antivirals in people living with human immunodeficiency virus and hepatitis C virus genotype 6 infections.

Authors:  Hsin-Yun Sun; Chien-Yu Cheng; Chi-Ying Lin; Chia-Jui Yang; Nan-Yao Lee; Bo-Huang Liou; Hung-Jen Tang; Yuang-Meng Liu; Chun-Yuan Lee; Tun-Chieh Chen; Yi-Chia Huang; Yuan-Ti Lee; Ming-Jui Tsai; Po-Liang Lu; Hung-Chin Tsai; Ning-Chi Wang; Tung-Che Hung; Shu-Hsing Cheng; Chien-Ching Hung
Journal:  World J Gastroenterol       Date:  2022-03-21       Impact factor: 5.742

3.  Glomerular filtration rate change during chronic hepatitis C treatment with Sofosbuvir/Ledipasvir in HCV/HIV Coinfected patients treated with Tenofovir and a boosted protease inhibitor: an observational prospective study.

Authors:  Cristina Aurora São Pedro Soeiro; Celina Andreia Melo Gonçalves; Marta Sofia Correia Marques; Maria Josefina Vazquez Méndez; Ana Paula Ribeiro Almeida Tavares; Ana Maria Lacerda Morgado Fernandes de Carvalho de Aboim Horta; Rui Manuel do Rosário Sarmento-Castro
Journal:  BMC Infect Dis       Date:  2018-08-03       Impact factor: 3.090
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.